The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the STOXX® Europe Total Market Index... Show more
The SPDR Portfolio Europe ETF seeks to provide investment results that, before fees and expenses, correspond to the total return performance of the STOXX Europe Total Market Index. The index is a free-float, market-capitalization-weighted benchmark designed to represent publicly traded Western European companies across the market-cap spectrum. The fund uses a sampling strategy, meaning it holds substantially all—but not necessarily every—security in the underlying index.
SPEU is a passively managed, non-leveraged equity ETF with an inception date of October 15, 2002, and one of the lowest expense ratios in its category at 0.07%. The portfolio holds approximately 1,700 securities, with a weighted average market capitalization exceeding $100 billion and a price-to-earnings (P/E) ratio in the mid-teens, reflecting a valuation tilt toward large, established companies.
Top holdings include semiconductor-equipment maker ASML, banks HSBC and Banco Santander, healthcare names Roche, Novartis, and AstraZeneca, energy producers Shell and TotalEnergies, and industrial and technology leaders Siemens and SAP. Sector allocation is led by financials at roughly one-quarter of assets, followed by industrials, healthcare, information technology, and consumer staples. This structure means the fund's returns are heavily influenced by European banks, pharmaceuticals, capital goods, and the broader cyclical-versus-defensive balance.
Western European equities sit at the intersection of several structural and cyclical forces. The region's financial sector, the largest single weight in SPEU, has benefited from a comparatively robust interest-rate environment that supports net interest margins at major lenders, while also remaining sensitive to credit quality and economic growth expectations.
Healthcare represents another core pillar, with diversified pharmaceutical and biotech firms providing relatively defensive earnings streams. The technology allocation is comparatively small versus U.S. benchmarks but is anchored by ASML and SAP, tying the fund to global semiconductor capital expenditure and enterprise software demand. Energy exposure links performance to oil and gas prices, while the heavy industrial weighting reflects European exporters' sensitivity to global trade, manufacturing activity, and currency movements.
Monetary policy remains a central theme. European policymakers have balanced inflation containment against the risk of weaker growth, and shifts in rate expectations tend to ripple through bank valuations, the euro's strength relative to the U.S. dollar, and exporter competitiveness. For U.S.-dollar-based investors, euro and British pound movements are an additional return driver because the fund reports in U.S. dollars.
Over the trailing 30 days, SPEU moved modestly higher, gaining on the order of 2% as measured from the closing level of roughly one month earlier. This compares with a slight decline of approximately 3–4% over the trailing quarter, indicating a market that consolidated and then stabilized rather than breaking decisively in either direction.
The recent stabilization coincided with firmer performance in financials and select technology holdings, while defensive healthcare and consumer staples names provided ballast. Energy holdings were more mixed, tracking fluctuations in crude prices. Because no single position exceeds roughly 4% of the portfolio and the top ten holdings combine for under 20% of assets, the fund's behavior reflects broad regional sentiment more than the movement of any individual stock.
For a diversified, low-cost core fund, this is consistent with a range-bound, macro-driven environment in which sector rotation—rather than a concentrated catalyst—set the tone for returns.
Tickeron's AI Screener is an AI-powered stock and ETF discovery platform that lets investors scan thousands of securities using technical indicators, fundamentals, volatility measures, AI-generated signals, market trends, price patterns, and customizable filters. It is designed to surface trending securities, breakout candidates, and new trading opportunities far more efficiently than manual screening. For investors monitoring European equity exposure alongside U.S. and global names, the AI Screener offers a practical way to organize large data sets into actionable watchlists.
Looking ahead, several structural factors are likely to shape SPEU's trajectory through 2026. The pace and direction of European interest-rate policy will remain pivotal, directly influencing bank profitability and the relative attractiveness of equity versus fixed income. Inflation trends and the resilience of consumer and business spending will determine whether the region's cyclical sectors can sustain momentum.
Semiconductor capital expenditure and broader technology demand will continue to matter for ASML and the information technology sleeve, while pharmaceutical pipelines and regulatory developments affect the healthcare allocation. Energy prices, trade policy, and the path of the euro and British pound against the U.S. dollar will also influence returns for dollar-based shareholders. Finally, capital flows into international equity funds and competitive dynamics among low-cost European ETFs may affect demand for the category overall. These themes—rather than any single data point—are likely to frame the fund's risk and opportunity set in the months ahead.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
SPEU broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 33 similar instances where the stock broke above the upper band. In 26 of the 33 cases the stock fell afterwards. This puts the odds of success at 79%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 44 of 59 cases where SPEU's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 75%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SPEU declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where SPEU's RSI Oscillator exited the oversold zone, 24 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 77%.
The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on SPEU as a result. In 73 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 86%.
The Moving Average Convergence Divergence (MACD) for SPEU just turned positive on October 15, 2026. Looking at past instances where SPEU's MACD turned positive, the stock continued to rise in 42 of 49 cases over the following month. The odds of a continued upward trend are 86%.
SPEU moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for SPEU crossed bullishly above the 50-day moving average on November 09, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +1.19% 3-day Advance, the price is estimated to grow further. Considering data from situations where SPEU advanced for three days, in 264 of 322 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Aroon Indicator entered an Uptrend today. In 260 of 323 cases where SPEU Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 80%.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows